Tachyphylaxis to capsaicin-induced cough and its reversal by indomethacin, in patients with the sinobronchial syndrome. 1992

M Fujimura, and Y Kamio, and S Sakamoto, and T Bando, and S Myou, and T Matsuda
Third Department of Internal Medicine, Kanazawa University School of Medicine, Japan.

Cough reflex testing with capsaicin has been used to study the pathophysiology of the cough reflex and the antitussive effects of various drugs. Although the reproducibility of capsaicin-induced cough has been well established in normal subjects, it is not known if prior challenge with capsaicin reduces the subsequent cough response to inhaled capsaicin in patients with the sinobronchial syndrome, a condition characterized by chronic upper and lower airway inflammation. Measurement of the capsaicin cough threshold, defined as the lowest concentration of capsaicin eliciting five or more coughs, was repeated four times at intervals of 15, 30 and 60 min in eleven patients with the SBS and ten normal subjects. The cough thresholds at 15, 30 and 60 min were greater than the initial value in patients with the SBS but not in normal subjects. In addition, we examined the effect of 4 days treatment with indomethacin (100 mg/day) on the cough thresholds measured twice at an interval of 15 min in eight patients with the SBS. Indomethacin increased the initial cough threshold and reduced the increment in the post-15 min cough threshold from the initial value compared with placebo, thus reducing the tachyphylaxis. These results indicate that chronic airway inflammation may be responsible for the decreased response (tachyphylaxis) to repeated inhalation of capsaicin, and suggest that cyclooxygenase products released by the airway inflammation may be involved in tachyphylaxis, cough receptor sensitivity to inhaled capsaicin, or both, in patients with the SBS.

UI MeSH Term Description Entries
D007213 Indomethacin A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES. Amuno,Indocid,Indocin,Indomet 140,Indometacin,Indomethacin Hydrochloride,Metindol,Osmosin
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002211 Capsaicin An alkylamide found in CAPSICUM that acts at TRPV CATION CHANNELS. 8-Methyl-N-Vanillyl-6-Nonenamide,Antiphlogistine Rub A-535 Capsaicin,Axsain,Capsaicine,Capsicum Farmaya,Capsidol,Capsin,Capzasin,Gelcen,Katrum,NGX-4010,Zacin,Zostrix,8 Methyl N Vanillyl 6 Nonenamide,NGX 4010,NGX4010
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D003371 Cough A sudden, audible expulsion of air from the lungs through a partially closed glottis, preceded by inhalation. It is a protective response that serves to clear the trachea, bronchi, and/or lungs of irritants and secretions, or to prevent aspiration of foreign materials into the lungs. Coughs
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

M Fujimura, and Y Kamio, and S Sakamoto, and T Bando, and S Myou, and T Matsuda
August 2010, Cough (London, England),
M Fujimura, and Y Kamio, and S Sakamoto, and T Bando, and S Myou, and T Matsuda
December 1994, Arerugi = [Allergy],
M Fujimura, and Y Kamio, and S Sakamoto, and T Bando, and S Myou, and T Matsuda
January 2022, Canadian respiratory journal,
M Fujimura, and Y Kamio, and S Sakamoto, and T Bando, and S Myou, and T Matsuda
January 2011, Acta oto-laryngologica,
M Fujimura, and Y Kamio, and S Sakamoto, and T Bando, and S Myou, and T Matsuda
August 1966, Circulation research,
M Fujimura, and Y Kamio, and S Sakamoto, and T Bando, and S Myou, and T Matsuda
August 1972, The American journal of physiology,
M Fujimura, and Y Kamio, and S Sakamoto, and T Bando, and S Myou, and T Matsuda
August 1992, The American review of respiratory disease,
M Fujimura, and Y Kamio, and S Sakamoto, and T Bando, and S Myou, and T Matsuda
January 1983, European journal of pharmacology,
M Fujimura, and Y Kamio, and S Sakamoto, and T Bando, and S Myou, and T Matsuda
February 1996, Pulmonary pharmacology,
M Fujimura, and Y Kamio, and S Sakamoto, and T Bando, and S Myou, and T Matsuda
August 2017, The Journal of allergy and clinical immunology,
Copied contents to your clipboard!